What is the first-line treatment for a 62-year-old male with a history of cerebrovascular accident (stroke), hypertension, and duodenal ulcer who has a random blood glucose in the 300 mg/dL range?

First-Line Treatment for Blood Glucose >300 mg/dL

For this 62-year-old male with blood glucose in the 300s, initiate a basal-bolus insulin regimen immediately, starting at 0.3 U/kg per day (half as basal insulin, half as bolus insulin before meals), with correction doses of rapid-acting insulin. 1

Rationale for Basal-Bolus Insulin

The 2021 Lancet Diabetes & Endocrinology guideline explicitly categorizes blood glucose >300 mg/dL as severe hyperglycemia requiring a more complex insulin regimen rather than simplified approaches 1. This patient falls squarely into this category and needs aggressive treatment.

Dosing Algorithm:

• Calculate total daily dose (TDD): 0.3 U/kg per day
• Split the dose: 50% as basal insulin (once or twice daily), 50% as bolus insulin (divided before meals)
• Add correction doses: Rapid-acting insulin before meals or every 6 hours if not eating
• Adjust as needed based on response

Important Considerations for This Patient's Comorbidities:

History of CVA (Stroke):

• Avoid hypoglycemia aggressively—hypoglycemia can worsen neurological outcomes 2
• Target glucose 140-180 mg/dL initially (not <140 mg/dL) 3, 2
• The European Stroke Organisation guidelines specifically recommend against tight glycemic control with IV insulin in stroke patients due to increased hypoglycemia risk without proven benefit 4
• Use subcutaneous insulin regimen rather than IV insulin unless critically ill 2

Duodenal Ulcer:

• This does NOT contraindicate insulin therapy
• Insulin is actually the safest option—metformin carries lactic acidosis risk and should be avoided in acute illness 1
• Other oral agents (DPP-4 inhibitors, SGLT2 inhibitors) are not appropriate for severe hyperglycemia >300 mg/dL 1

Hypertension:

• No specific modification to insulin regimen needed
• Ensure adequate hydration during treatment

Monitoring Requirements:

• Point-of-care glucose monitoring: Before each meal and at bedtime if eating; every 4-6 hours if NPO 3
• Watch for hypoglycemia: Glucose <70 mg/dL requires immediate treatment
• Target range: 140-180 mg/dL for the first 24-48 hours 3

Common Pitfalls to Avoid:

1. Do NOT use oral agents alone for glucose >300 mg/dL—they are inadequate for severe hyperglycemia 1
2. Do NOT aim for tight control (<140 mg/dL) initially in a patient with stroke history—this increases hypoglycemia risk without benefit 4
3. Do NOT use sliding scale insulin alone—it is reactive rather than proactive and leads to poor control
4. Do NOT withhold basal insulin even if patient is NPO—only withhold prandial insulin with poor oral intake 1

If Patient is Critically Ill or Has Altered Mental Status:

Switch to continuous IV insulin infusion with hourly glucose monitoring until stable, then transition to subcutaneous regimen 1, 3. However, based on the question, this appears to be a non-critically ill hospitalized patient.

Transition Planning:

Once glucose is controlled (typically 24-72 hours), assess for:

• Need for long-term diabetes management
• Possible precipitants (infection, medication non-compliance, new-onset diabetes)
• Outpatient diabetes education and follow-up